State Street’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.5M | Sell |
2,572,240
-46,250
| -2% | -$1.68M | ﹤0.01% | 1341 |
|
|
2025
Q1 | $94.8M | Sell |
2,618,490
-104,134
| -4% | -$3.77M | ﹤0.01% | 1292 |
|
|
2024
Q4 | $115M | Buy |
2,722,624
+58,547
| +2% | +$2.46M | ﹤0.01% | 1263 |
|
|
2024
Q3 | $148M | Sell |
2,664,077
-33,024
| -1% | -$1.83M | 0.01% | 1096 |
|
|
2024
Q2 | $111M | Sell |
2,697,101
-154,149
| -5% | -$6.34M | ﹤0.01% | 1195 |
|
|
2024
Q1 | $133M | Sell |
2,851,250
-401,252
| -12% | -$18.7M | 0.01% | 1131 |
|
|
2023
Q4 | $156M | Buy |
3,252,502
+684,644
| +27% | +$32.7M | 0.01% | 1002 |
|
|
2023
Q3 | $91.5M | Buy |
2,567,858
+102,408
| +4% | +$3.65M | 0.01% | 1233 |
|
|
2023
Q2 | $114M | Sell |
2,465,450
-280,257
| -10% | -$12.9M | 0.01% | 1130 |
|
|
2023
Q1 | $110M | Sell |
2,745,707
-197,060
| -7% | -$7.9M | 0.01% | 1118 |
|
|
2022
Q4 | $136M | Buy |
2,942,767
+383,223
| +15% | +$17.8M | 0.01% | 973 |
|
|
2022
Q3 | $106M | Buy |
2,559,544
+102,236
| +4% | +$4.23M | 0.01% | 1077 |
|
|
2022
Q2 | $147M | Buy |
2,457,308
+508,624
| +26% | +$30.3M | 0.01% | 916 |
|
|
2022
Q1 | $142M | Buy |
1,948,684
+269,843
| +16% | +$19.6M | 0.01% | 1069 |
|
|
2021
Q4 | $141M | Buy |
1,678,841
+204,976
| +14% | +$17.2M | 0.01% | 1043 |
|
|
2021
Q3 | $133M | Buy |
1,473,865
+102,990
| +8% | +$9.29M | 0.01% | 1060 |
|
|
2021
Q2 | $131M | Sell |
1,370,875
-239,964
| -15% | -$22.9M | 0.01% | 1094 |
|
|
2021
Q1 | $183M | Sell |
1,610,839
-65,460
| -4% | -$7.45M | 0.01% | 832 |
|
|
2020
Q4 | $232M | Sell |
1,676,299
-140,693
| -8% | -$19.5M | 0.01% | 700 |
|
|
2020
Q3 | $149M | Sell |
1,816,992
-161,252
| -8% | -$13.3M | 0.01% | 786 |
|
|
2020
Q2 | $155M | Sell |
1,978,244
-251,107
| -11% | -$19.6M | 0.01% | 750 |
|
|
2020
Q1 | $99.1M | Buy |
2,229,351
+30,604
| +1% | +$1.36M | 0.01% | 864 |
|
|
2019
Q4 | $93.9M | Buy |
2,198,747
+87,859
| +4% | +$3.75M | 0.01% | 1089 |
|
|
2019
Q3 | $90.3M | Sell |
2,110,888
-8,844
| -0.4% | -$378K | 0.01% | 1067 |
|
|
2019
Q2 | $135M | Buy |
2,119,732
+198,021
| +10% | +$12.6M | 0.01% | 862 |
|
|
2019
Q1 | $133M | Sell |
1,921,711
-129,928
| -6% | -$9.01M | 0.01% | 848 |
|
|
2018
Q4 | $89.2M | Buy |
2,051,639
+339,115
| +20% | +$14.7M | 0.01% | 968 |
|
|
2018
Q3 | $131M | Buy |
1,712,524
+63,773
| +4% | +$4.87M | 0.01% | 901 |
|
|
2018
Q2 | $127M | Sell |
1,648,751
-368,544
| -18% | -$28.3M | 0.01% | 886 |
|
|
2018
Q1 | $103M | Buy |
2,017,295
+420,776
| +26% | +$21.5M | 0.01% | 985 |
|
|
2017
Q4 | $74.1M | Buy |
1,596,519
+81,448
| +5% | +$3.78M | 0.01% | 1195 |
|
|
2017
Q3 | $80.7M | Sell |
1,515,071
-21,214
| -1% | -$1.13M | 0.01% | 1107 |
|
|
2017
Q2 | $95.4M | Buy |
1,536,285
+270,729
| +21% | +$16.8M | 0.01% | 984 |
|
|
2017
Q1 | $85.8M | Sell |
1,265,556
-131,633
| -9% | -$8.92M | 0.01% | 1035 |
|
|
2016
Q4 | $98.2M | Sell |
1,397,189
-80,247
| -5% | -$5.64M | 0.01% | 919 |
|
|
2016
Q3 | $105M | Buy |
1,477,436
+208,750
| +16% | +$14.8M | 0.01% | 854 |
|
|
2016
Q2 | $62M | Sell |
1,268,686
-15,638
| -1% | -$765K | 0.01% | 1076 |
|
|
2016
Q1 | $81.3M | Buy |
1,284,324
+300,901
| +31% | +$19.1M | 0.01% | 927 |
|
|
2015
Q4 | $110M | Buy |
983,423
+126,542
| +15% | +$14.2M | 0.01% | 791 |
|
|
2015
Q3 | $82.5M | Buy |
856,881
+19,831
| +2% | +$1.91M | 0.01% | 907 |
|
|
2015
Q2 | $85.7M | Buy |
837,050
+317,063
| +61% | +$32.5M | 0.01% | 944 |
|
|
2015
Q1 | $32.3M | Sell |
519,987
-5,794
| -1% | -$360K | ﹤0.01% | 1496 |
|
|
2014
Q4 | $23.1M | Buy |
525,781
+146,916
| +39% | +$6.45M | ﹤0.01% | 1700 |
|
|
2014
Q3 | $21.4M | Buy |
378,865
+286,995
| +312% | +$16.2M | ﹤0.01% | 1696 |
|
|
2014
Q2 | $4.12M | Buy |
91,870
+27,889
| +44% | +$1.25M | ﹤0.01% | 2697 |
|
|
2014
Q1 | $3.13M | Buy |
+63,981
| New | +$3.13M | ﹤0.01% | 2828 |
|